{{Rsnum
|rsid=3785883
|Gene=MAPT
|Chromosome=17
|position=45977067
|Orientation=plus
|GMAF=0.1708
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAPT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 24.8 | 71.7
| HCB | 3.6 | 23.4 | 73.0
| JPT | 0.9 | 31.0 | 68.1
| YRI | 2.7 | 31.3 | 66.0
| ASW | 3.5 | 35.1 | 61.4
| CHB | 3.6 | 23.4 | 73.0
| CHD | 4.6 | 27.5 | 67.9
| GIH | 7.9 | 30.7 | 61.4
| LWK | 7.3 | 28.2 | 64.5
| MEX | 6.9 | 27.6 | 65.5
| MKK | 6.5 | 43.2 | 50.3
| TSI | 2.9 | 21.6 | 75.5
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19558713
|Title=Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease
|OA=1
}}

{{PMID|15297935|OA=1
}} Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

{{PMID|17192721}} Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.

{{PMID|17266761|OA=1
}} Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.

{{PMID|18065436|OA=1
}} The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

{{PMID|18072964|OA=1
}} No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease.

{{PMID|18509094|OA=1
}} Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

{{PMID|18541914|OA=1
}} Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.

{{PMID|19063963|OA=1
}} Genetic susceptibility in Parkinson's disease.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}